The aim is to evaluate the effectiveness of the BCID2 panel for detecting bloodstream infections in patients with cancer.
Evaluated the BCID2 panel in diagnosing bloodstream infections.
Compared results of BCID2 with traditional blood culture methods.
Assessed antimicrobial sensitivity in relation to PCR results.
BCID2 panel provided faster results compared to blood cultures.
High correlation observed between BCID2 results and traditional blood culture identification.
Abstract
BCID2 panel provided faster results and its results showed a high correlation with traditional blood culture identification and antimicrobial sensitivity results.